View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
November 26, 2021

UKHSA study shows safety of Covid-19 vaccine use during pregnancy

No fully vaccinated pregnant women were admitted to intensive care with Covid-19 from February to September this year.

The UK Health Security Agency (UKHSA) has found that pregnant women who received a Covid-19 vaccine had positive birth outcomes in a study.

Between January and August 2021, 355,299 women gave birth, with 24,759 of them receiving at least one Covid-19 vaccine dose before delivery.

Data demonstrated that women infected with Covid-19 during their late pregnancy period were more likely to have severe disease, which needed hospitalisation and intensive care admission.

Between February and September, no fully inoculated pregnant women were admitted to intensive care with Covid-19 in England.

The study found a comparable trend with greatly reduced stillbirth risk, prematurity, and reduced birth weight in vaccinated and unvaccinated women, but vaccinated people were substantially more protected against serious Covid-19 than those who did not receive the vaccine.

Data also showed that women residing in the most deprived regions of England were less probable to receive the Covid-19 vaccine, with at least one dose before delivery.

Only 7.8% of women from such areas were vaccinated during pregnancy versus 26.5% in less deprived regions.

Nearly 17.5% of the pregnant women from a White background were found to be the most vaccinated while 5.5% of pregnant women of Black ethnicity were also the least likely to be inoculated during delivery.

UKHSA Immunisation head Dr Mary Ramsay said: “Every pregnant woman who has not yet been vaccinated should feel confident to go and get the jab, and that this will help to prevent the serious consequences of catching Covid-19 in pregnancy.

“This accumulating evidence will also allow midwives and other health professionals to provide better information to pregnant women and help to drive uptake higher.”

This August, the UK Government launched a new trial to decide on the best interval between Covid-19 vaccine doses for pregnant women.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Clinical Trials Arena